Blog
HPV-Positive Oropharyngeal Cancers: Predicting Treatment Response Using ddPCR
BlogDuring this year’s AACR Annual Meeting we spoke to Julianna Supplee, Research Technician at the Robert and Renée Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute, to learn more about the team’s most recent study on the use of plasma HPV cell-free DNA as an early predictor of treatment response in patients with advanced oropharyngeal cancer.
Read More
Using Cell-free DNA as a Marker for Liver Cancer Diagnosis
BlogDuring this year’s AACR conference we spoke to Kang Zhang, M.D., Ph.D. from the University of California, San Diego about the collaborative work he has been doing with the Laboratory for Advanced Medicine. He discusses their recent study findings on the use of a blood-based method to look at cell-free DNA as a marker for liver cancer diagnosis and prognosis.
Read More
Genomic Profiling in Cancer: Matching Patients to Precision Trials, Guiding Patients to the Right Treatment
BlogWe recently spoke to Gaurav Singal, Vice President of Data Strategy and Product Development at Foundation Medicine, to learn more about how their SmartTrialsTM technology platform has enabled patients to be rapidly matched to precision trials, based on their unique tumor biomarkers.
Read More
Accelerating the Development of Organs-on-Chips
BlogEmulate, Inc. and AstraZeneca recently announced they have formed a collaborative partnership which will see Emulate's Organs-on-Chips technology embedded in AstraZeneca's Innovative Medicines and Early Development Biotech Unit.
Read More
Deploying Cloud Technologies to Fight Pediatric Cancer
BlogThe St. Jude Cloud is a recently-launched online data-sharing and collaboration platform that provides access to the largest public repository of pediatric cancer genomics data. We caught up with Jinghui Zhang, PhD, from St. Jude Children’s Research Hospital to discuss the cloud and its impact on pediatric research.
Read More
Newly Discovered Biomarker Could Help Diagnose Hearing Loss Earlier
BlogIn collaboration with UConn, Sensorion have identified the first potential biomarker for noise-induced hearing loss, findings which were recently presented at the 53rd American Neurotology Society Annual Spring Meeting.
Read More
Next Generation Sequencing for the Masses?
BlogThermo Fisher Scientific’s Oncomine Dx Target Test, a cancer diagnostics panel, is set to be made available to 160 million people in the US through both Medicare and Medicaid and private insurers. We spoke with Joydeep Goswami, president of Clinical NGS and Oncology for Thermo Fisher Scientific, about the progress of NGS tests in the clinic.
Read More
New Method to Rule out Early Stage Lung Cancer
BlogWe spoke to Dr Albert Luderer, CEO of Integrated Diagnostics to learn about the challenges of diagnosing lung nodules as benign or malignant, and how the Xpresys Lung 2 liquid biopsy test can help improve this process.
Read More
Harnessing Big Data in the Fight Against Pediatric Cancer
BlogWe recently spoke to Dr Samuel L. Volchenboum to learn more about his current research within the areas of pediatric cancer and inflammatory bowel disease. He discusses current challenges of harnessing data and informatics, and strategies for optimizing data to enhance the impact of research.
Read More
Revolutionizing the World of Pipetting
BlogNecessity is the mother of invention, and nowhere is this more clearly demonstrated than in the laboratory. We caught up with Alex Studer, VP of Marketing and Innovation at INTEGRA Biosciences, to discuss the company’s aim to transform the world of pipetting.
Read More
